## **Core Concept**
Leuprolide and ganirelix are both used in the management of hormone-sensitive cancers and conditions like endometriosis, but they belong to different classes of drugs. Leuprolide is a **gonadotropin-releasing hormone (GnRH) agonist**, while ganirelix is a **GnRH antagonist**. This fundamental difference in their mechanisms of action leads to distinct pharmacological effects.

## **Why the Correct Answer is Right**
Ganirelix acts by competitively inhibiting the GnRH receptor, which leads to an immediate decrease in the secretion of **luteinizing hormone (LH) and follicle-stimulating hormone (FSH)** from the anterior pituitary gland. This rapid action makes ganirelix useful for preventing premature LH surges during controlled ovarian hyperstimulation for assisted reproduction. On the other hand, leuprolide, as a GnRH agonist, initially stimulates the GnRH receptors, leading to an increase in LH and FSH secretion. With continued administration, it downregulates GnRH receptors, ultimately decreasing LH and FSH levels.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, so there's no explanation needed.
- **Option B:** This option is not provided, so there's no explanation needed.
- **Option C:** This option is not provided, so there's no explanation needed.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **GnRH antagonists like ganirelix can be used to prevent premature ovulation in assisted reproductive technologies (ART) without the initial flare effect seen with GnRH agonists**. This can be particularly beneficial in ART protocols to synchronize follicular growth and improve success rates.

## **Correct Answer:** D. has a more rapid onset of action.